Lidokain/Adrenalin Aguettant

Lidocaine hydrochloride, the active ingredient in Lidokain/Adrenalin Aguettant, is a local anesthetic presented as a sterile solution for epidural, infiltration, and perineural use. It provides temporary loss of sensation for minor surgical procedures and other indicated anesthetic applications.

GNH USA supplies Lidokain/Adrenalin Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidokain/Adrenalin is a local anesthetic combination used in procedures involving the peripheral and central nervous system pathways. - Minor surgical procedures: provides local anesthesia to facilitate the operation. - Infiltration anesthesia: numbs tissue for minor dermatologic or dental work. - Perineural (nerve block) anesthesia: blocks nerve transmission for targeted analgesia. - Epidural anesthesia: produces regional anesthesia for obstetric or surgical procedures.

Adverse reactions may occur following administration of Lidokain/Adrenalin.

Common Side Effects: - Transient burning or stinging at the injection site - Mild dizziness or light‑headedness - Nausea or vomiting - Temporary tachycardia - Localized swelling or erythema - Headache

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Cardiac arrhythmia or myocardial ischemia - Seizures or central nervous system toxicity - Methemoglobinemia - Persistent hypotension - Respiratory depression

Before using Lidokain/Adrenalin, consider the following safety measures. - Allergy assessment: verify no known hypersensitivity to lidocaine or epinephrine. - Cardiovascular status: use cautiously in patients with heart disease or hypertension. - Pregnancy: avoid unless the potential benefit justifies the potential risk. - Drug interactions: review concomitant medications for possible additive effects. - Dosage limits: adhere to the prescriber's maximum recommended dose. - Store at room temperature: keep in the original container, protect from light and moisture.

Lidokain/Adrenalin may interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine): may increase lidocaine toxicity. - Beta‑blockers: can potentiate epinephrine‑induced hypertension. - Monoamine oxidase inhibitors: risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: may increase bleeding risk. - Diuretics: may alter plasma concentrations of lidocaine. - General anesthetics: may enhance central nervous system depression.